Among these antioxidants, GSH seems to be the determining agent because it is selectively decreased in the brains of patients with these neurodegenerative diseases (e.g., Parkinsons disease, Alzheimers disease, and Amyotrophic lateral sclerosis) [74]
Thus, while sulforaphane has shown some potential to lessen behaviors associated with established disease pathologies, its strongest effects in preclinical models appear to be involved in reducing disease risk before onset of pathological manifestations
Picomolar to nanomolar activity suggests high receptor affinity and potent biological signalling, which is encouraging for topical delivery where only a fraction of applied compound reaches the follicle
Together, these will help form a diagnosis
AMPK activity follows a diurnal pattern, peaking in the early morning and declining through the evening
What Is Oxidative Stress and How Does It Accelerate Aging